UK markets close in 1 hour 53 minutes

Shandong Xinhua Pharmaceutical Co Ltd (XIN.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.6300-0.0100 (-1.56%)
As of 11:41AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
7,935,876
8,100,845
7,502,987
6,560,078
6,005,587
Cost of revenue
5,693,549
5,709,142
5,465,656
4,786,410
4,190,990
Gross profit
2,242,327
2,391,702
2,037,331
1,773,667
1,814,597
Operating expenses
Research development
449,026
419,240
345,659
341,367
298,347
Selling general and administrative
857,833
967,005
814,858
688,890
736,911
Total operating expenses
1,659,488
1,779,509
1,493,908
1,274,681
1,271,723
Operating income or loss
582,839
612,193
543,423
498,986
542,874
Interest expense
38,561
41,149
49,707
53,103
59,759
Income before tax
516,538
532,686
471,774
421,233
411,638
Income tax expense
19,177
26,579
45,665
59,159
64,525
Income from continuing operations
497,361
506,107
426,110
362,074
347,113
Net income
486,788
496,512
411,063
348,548
324,860
Net income available to common shareholders
486,788
496,512
411,063
348,548
324,860
Basic EPS
0.75
0.74
0.62
0.56
0.52
Diluted EPS
0.74
0.72
0.61
0.56
0.52
Basic average shares
680,999
670,962
663,005
622,408
624,730
Diluted average shares
689,648
689,600
673,874
622,408
624,730